In recent years, personalised medicine has been a growing area of research, with promising individualised treatments for a whole range of diseases including cancer. This has involved the study of genes and changes in our DNA. By understanding our genetic information, we have the potential to transform the NHS and revolutionise patient treatment. In this short talk, Sarah Atkinson will consider the benefits and risks of DNA testing technology and if applying this technology will improve outcomes.
We will look at whether ‘personalised’ is automatically better in the case of medicine or if medicine should be more about ‘we’.
This event is part of the Ulster University Healthy Ageing programme for the NI Science Festival.